HB 2536 requires pharmaceutical manufacturers to disclose to the Texas Health and Human Services Commission (HHSC) when a drug’s price increases 15% or more compared to the previous year, or 40% or more over three calendar years. The new law also requires annual reporting of detailed price information by manufacturers, pharmacy benefit managers, and health benefit plans, and charges the HHSC with making this information available online to the public.
Now in its ninth year, our annual Technology May-rathon focuses on all things tech – including issues, trends, and developments of interest to Health Law Scanreaders. So be sure to check out and register for some of the webinars and in-person programs below:
May 7 - Digital Health Privacy: Avoiding the Landmines featuring Reece Hirsch
May 14 - Development of Blockchain in Healthcare featuring Jonelle Saunders
May 16 - Fast Break: Digital Health Regulatory Update featuring Michele Buenafe and Jake Harper
May 20 - Making It Personal: Regulatory Challenges and Opportunities featuring Kathleen Sanzo, Michele Buenafe, and Jacqueline Berman
May 22 - Advancements in Telehealth Law featuring Jake Harper and Anthony Ferrara
May 22 - Opportunities in Food and Agricultural Tech featuring Robert Hibbert
May 23 - Latest Developments in IP, FDA, and AI featuring Michele Buenafe and Christopher Halliday
And don’t forget our Technology May-rathon page for our full list of events on AI, Global Commerce, Fintech, and much more.
“Medicare for All” has appeared in the nation’s political dialogue as we head into the next election cycle, with a number of plans being proposed by Democratic lawmakers. Recent public opinion polls show a growing surge in popularity for expanding the federal program that currently insures older Americans. Yet the polls also show a decline in favorability for Medicare for All when respondents are asked about the details of the plans. While there appears to be general agreement that Americans should have access to affordable coverage, the Democratic plans differ over options for reforming the health insurance system. To that end, the Medicare for All plans can be divided into one of two categories: a single payor or a public option plan. From there, the proposals diverge over a mix of fault lines, tradeoffs, and potential for disruption.